Overexpression of epstein-barr virus-encoded microRNA-BART7 in undifferentiated nasopharyngeal carcinoma

Anticancer Research

Volumn 32, Issue 8, 2012, Pages 3201-3210

  Chan, Jimmy Yu Wai ^a   Gao, Wei ^a   Ho, Wai Kuen ^a   Wei, William Ignace ^a   Wong, Thian Sze ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cancer related pathways; EBV; EBV miR BART7; Nasopharyngeal carcinoma; NPC screening; Oncogenic role

Indexed keywords

BAMHI A RIGHTWARD TRANSCRIPT 7 MICRORNA; CISPLATIN; MICRORNA; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS RNA;

ADULT; AGED; ARTICLE; CANCER STAGING; CARCINOGENICITY; CARCINOMA CELL; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SENSITIVITY; EPSTEIN BARR VIRUS; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; MALE; NASOPHARYNX CARCINOMA; PLASMA; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VALIDATION STUDY; VIRUS EXPRESSION;

EID: 84865682751     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Wei WI and Sham JS: Nasopharyngeal carcinoma. Lancet 365: 2041-2054, 2005.
2. Pathmanathan R, Prasad U, Sadler R, Flynn K and Raab-Traub N: Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med 333: 693-698, 1995.
3. Ambros V: The functions of animal microRNAs. Nature 431: 350-355, 2004.
4. Bushati N and Cohen SM: microRNA functions. Annu Rev Cell Dev Biol 23: 175-205, 2007.
5. Cai X, Schäfer A, Lu S, Bilello JP, Desrosiers RC, Edwards R, Raab-Traub N and Cullen BR: Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed. PLoS Pathog 2: e23, 2006.
6. Grundhoff A, Sullivan CS and Ganem D: A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses. RNA 12: 733-750, 2006.
7. Chen SJ, Chen GH, Chen YH, Liu CY, Chang KP, Chang YS and Chen HC: Characterization of Epstein-Barr virus miRNAome in nasopharyngeal carcinoma by deep sequencing. PloS one 5: e12745, 2010.
8. Huang DP, Ho JH, Poon YF, Chew EC, Saw D, Lui M, Li CL, Mak LS, Lai SH and Lau WH: Establishment of a cell line (NPC/HK1) from a differentiated squamous carcinoma of the nasopharynx. Int J Cancer 26: 127-132, 1980.
9. Glaser R, Zhang HY, Yao KT, Zhu HC, Wang FX, Li GY, Wen DS and Li YP: Two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus that were derived from nasopharyngeal carcinomas. Proc Natl Acad Sci USA 86: 9524-9528, 1989.
10. Zhang Y, Gao HY, Feng HX, Deng L, Huang MY, Hu B, Cheng G, Wu QL, Cui NJ and Shao JY: Quantitative analysis of Epstein-Barr virus DNA in plasma and peripheral blood cells in patients with nasopharyngeal carcinoma. Zhonghua Yi Xue Za Zhi 84: 982-986, 2004.
11. Yuan H, Yang BB and Xu ZF: The clinical value of quantitative analysis of plasma Epstein-Barr virus DNA in patients with nasopharyngeal carcinoma. Zhonghua Er Bi Yan Hou Ke Za Zhi 39: 162-165, 2004.
12. Shotelersuk K, Khorprasert C, Sakdikul S, Pornthanakasem W, Voravud N and Mutirangura A: Epstein-Barr virus DNA in serum/plasma as a tumor marker for nasopharyngeal cancer. Clin Cancer Res 6: 1046-1051, 2000.
13. Li B, Chen Z, Liu L, Huang Z, Huang Z and Xie S: Differences in sensitivity to HMME-mediated photodynamic therapy between EBV+ C666-1 and EBV - CNE2 cells. Photodiagnosis Photodyn Ther 7: 204-209, 2010.